Phase I Trial: T4 Immunotherapy of Head and Neck Cancer
King's College London
King's College London
Suzhou Genhouse Bio Co., Ltd.
Affiliated Hospital of Nantong University
Instituto do Cancer do Estado de São Paulo
Jiangxi Provincial Cancer Hospital
NGM Biopharmaceuticals, Inc
Irish Research Radiation Oncology Group
Mahidol University
Zhujiang Hospital
University of Milan
Wellmarker Bio
Kousai Bio Co., Ltd.
R-Pharm
University of Milan
Eye & ENT Hospital of Fudan University
Federico II University
West China Hospital
Ottawa Hospital Research Institute
Chinese PLA General Hospital
Universitair Ziekenhuis Brussel
Centre hospitalier de l'Université de Montréal (CHUM)
University of Virginia
Jiangxi Provincial Cancer Hospital
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
HRYZ Biotech Co.
Tongji Hospital
Icahn School of Medicine at Mount Sinai
University of Virginia
Kuwait Cancer Control Center
Northwestern University
Sun Yat-sen University
ISA Pharmaceuticals
Sixth Affiliated Hospital, Sun Yat-sen University
Poitiers University Hospital
National Cancer Centre, Singapore
Nanfang Hospital, Southern Medical University
Seoul St. Mary's Hospital
University Hospital, Ghent
ISA Pharmaceuticals
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
University College, London
Sunnybrook Health Sciences Centre
Fudan University
Fudan University
University Medical Center Groningen
Ruijin Hospital
Sichuan University
Qilu Pharmaceutical Co., Ltd.
Sun Yat-sen University
Nanfang Hospital, Southern Medical University